Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.
| Last: | $0.0001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0001 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0.0001 |
| Volume: | 500 |
| Last Trade Date Time: | 03/02/2026 10:03:18 am |
| Market Cap: | $2,618 |
|---|---|
| Float: | 24,252,505 |
| Insiders Ownership: | 3.5% |
| Institutions: | 4 |
| Short Percent: | 2015026% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | http://www.anthera.com |
| Country: | US |
| City: | Hayward |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Anthera Pharmaceuticals Inc (OTCMKTS: ANTH).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
